BJBlair Jones

Blair Jones

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Blair Jones has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Aditya Bharatha

    Division of Neuroradiology, Department of Medical Imaging, Unity Health Toronto–St. Michael’s Hospital, University of Toronto, 30 Bond St, Toronto, ON, Canada M5B 1W8

    1 shared publication
  • Amy W. Lin

    From the Division of Diagnostic Neuroradiology (R.O., T.R.L., S.M., A.W.L., A.B., S.S.), Department of Medical Imaging, St. Michael’s Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada

    1 shared publication
  • Monica Tafur

    Division of Abdominal and Breast Imaging (M.T.), Department of Medical Imaging, St. Michael’s Hospital, Unity Health Toronto, University of Toronto, Toronto, Ontario, Canada

    1 shared publication
  • Richard Olatunji

    Division of Diagnostic and Therapeutic Neuroradiology (J.D.B.D., R.O.), Department of Medical Imaging, St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada

    1 shared publication
  • Shobhit Mathur

    Departments of Neurosurgery and Medical Imaging, St. Michael’s Hospital, Toronto, Canada

    1 shared publication
  • Suradech Suthiphosuwan

    Department of Medical Imaging, University of Toronto, Toronto, Canada

    1 shared publication

Latest Publications

  • Open Access

    Delayed Gadolinium Leakage in Ocular Structures on Brain MR Imaging: Prevalence and Associated Factors

    by Richard Olatunji, Timothy Reynold Lim, Blair Jones, Monica Tafur, Shobhit Mathur, Amy W. Lin, Aditya Bharatha, Suradech Suthiphosuwan

    BACKGROUND AND PURPOSE: Gadolinium leakage in ocular structures (GLOS) is characterized by hyperintense signal in the chambers of the eye on FLAIR and has been reported in association with blood-ocular barrier breakdown in patients with ischemic strokes. The underlying mechanism of GLOS remains poorly understood; however, some studies suggest it may be part of a physiologic excretion pathway of gadolinium. This study aimed to determine the prevalence of GLOS in an unselected patient population. MATERIALS AND METHODS: A retrospective analysis was conducted on 439 patients who underwent brain MR imaging within 7 days of receiving a gadolinium-based contrast agent injection for a prior MR imaging study. Clinical, imaging, and laboratory data were collected. Descriptive and logistic regression analyses were performed. RESULTS: GLOS was observed in 26 of 439 patients (6%). The occurrence of GLOS varied with time, with 3 (12%), 14 (54%), 8 (31%), and 1 (4%) patient showing GLOS within 24, 25–72, 73–120, and >120 hours after gadolinium-based contrast agent injection, respectively. Patients with GLOS were older (median age: 72 versus 55 years, P = .001) and had higher median serum creatinine levels (73 versus 64 µmol/L, P = .005) and a lower median estimated glomerular filtration rate (84 versus 101 mL/min/1.73 m2, P < .001). A shorter median time interval between gadolinium-based contrast agent injection and the index brain MR imaging was observed in the group positive for GLOS (62 versus 91 hours, P = .003). Multivariable regression analysis identified the estimated glomerular filtration rate (OR = 0.970; 95% CI, 0.049–0.992; P = .008) and time interval since gadolinium-based contrast agent injection (OR = 0.987; 95% CI, 0.977–0.997; P = .012) as independent factors associated with GLOS. CONCLUSIONS: GLOS was observed in only a small percentage of patients receiving gadolinium-based contrast agent within 7 days before brain MR imaging. This phenomenon was noted in patients with normal findings on brain MR imaging and those with various CNS pathologies, and it was associated with lower estimated glomerular filtration rates and shorter time intervals after gadolinium-based contrast agent injection. While GLOS may be a physiologic gadolinium-based contrast agent excretion pathway, the presence of ocular disease was not formally evaluated in the included population. Awareness of GLOS is nonetheless useful for appropriate radiologic interpretation.